Incidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie

被引:5
|
作者
Bechade, Clemence [1 ,2 ]
Dejardin, Olivier [1 ,2 ]
Bara, Simona [3 ,4 ]
Bouvier, Veronique [1 ,2 ,5 ]
Guizard, Anne-Valerie [2 ,6 ]
De Mil, Remy [1 ,2 ]
Troussard, Xavier [1 ,3 ,7 ]
Lobbedez, Thierry [1 ,2 ]
Launoy, Guy [1 ,2 ]
机构
[1] CHU Caen, Ave Cote Nacre, F-14033 Caen, France
[2] Ctr Francois Baclesse, Cancers & Prevent, INSERM UCBN U1086, Caen, France
[3] Francim Reseau Francais Registres Canc, Toulouse, France
[4] Hop Cotentin, Manche Canc Registry, Octeville, France
[5] Ctr Francois Baclesse, Calvados Digest Canc Registry, Canc & Prevent, INSERM,U1086, Caen, France
[6] Ctr Francois Baclesse, Calvados Gen Canc Registry, Cancers & Prevent, INSERM,U1086, Caen, France
[7] CHU Caen, Basse Normandie Haematol Malignancies Canc Regist, Ave Cote Nacre, F-14033 Caen, France
关键词
Cancer; Dialysis; Incidence; Renal replacement therapy; RISK SCORE; INSUFFICIENCY; VALIDATION; MORTALITY; OUTCOMES; DISEASE; COHORT;
D O I
10.1007/s40620-016-0356-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims To estimate the incidence of chronic dialysis in patients with a history of cancer and assess how renal replacement therapy is initiated in this population. Methods We merged data from cancer registries and hospital databases in one French region to identify patients with an incident cancer between 2001 and 2008 who started chronic dialysis. Results Mean participation time was 3.4 +/- 2.7 years. Males comprised 58.5 % of participants. During the study period, 74 chronic dialysis treatments were initiated. Chronic interstitial nephritis was the leading cause of end-stage renal disease (21.6 %), and 46.6 % of dialysis initiation cases were unplanned. The incidence rate of chronic dialysis initiation in the population of incident cancer patients was 370 per million population/year (74 events/199,809 person-years). After age-adjustment, the standardized incidence ratio was 1.26, 95 % confidence interval 0.98-1.57, p = 0.55. Conclusion Cancer patients are known to be at risk of chronic kidney disease. However, the standardized incidence ratio of chronic dialysis initiation did not differ significantly between cancer patients and the general population. Further studies should be performed to identify the barriers to starting renal replacement therapy in cancer patients.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 50 条
  • [1] Incidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie
    Clémence Béchade
    Olivier Dejardin
    Simona Bara
    Véronique Bouvier
    Anne-Valérie Guizard
    Rémy De Mil
    Xavier Troussard
    Thierry Lobbedez
    Guy Launoy
    Journal of Nephrology, 2018, 31 : 111 - 118
  • [2] Incidence, Patterns, and Characteristics of Patients With Acute Kidney Injury Requiring Renal Replacement Therapy in Cancer Settings
    Siddiq, Summra
    Hussain, Zakia
    Mubarakali, Janmohamed
    Nazir, Anam
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [3] Survival of patients with cancer starting chronic dialysis: Data from kidney and cancer registries in lower Normandy
    Bechade, Clemence
    Dejardin, Olivier
    Bara, Simona
    Bouvier, Veronique
    Guizard, Anne-Valerie
    De Mil, Remy
    Troussard, Xavier
    Launoy, Guy
    Lobbedez, Thierry
    NEPHROLOGY, 2018, 23 (12) : 1125 - 1130
  • [4] A snapshot of European registries on chronic kidney disease patients not on kidney replacement therapy
    Jager, Kitty J.
    Asberg, Anders
    Collart, Frederic
    Couchoud, Cecile
    Evans, Marie
    Finne, Patrik
    Peride, Ileana
    Rychlik, Ivan
    Massy, Ziad A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (01) : 8 - 13
  • [5] Renal replacement therapy in cancer patients with acute kidney injury (Review)
    Lupusoru, Mircea
    Lupusoru, Gabriela
    Ailincai, Ioana
    Fratila, Georgiana
    Andronesi, Andreea
    Micu, Elena
    Banu, Mihaela
    Costea, Radu
    Ismail, Gener
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (02)
  • [6] Renal replacement therapy in children: data from 12 registries in Europe
    Bert J. van der Heijden
    Paul C. W. van Dijk
    Kate Verrier-Jones
    Kitty J. Jager
    J. Douglas Briggs
    Pediatric Nephrology, 2004, 19 : 213 - 221
  • [7] Haematological malignancies (HM) in Basse-Normandie (BN): Incidence and clinical and biological characteristics over the period 1997-2005 in patients less than 25 years old
    Collignon, A.
    Duchenet, V.
    Mouchel, D.
    Malet, M.
    Cornet, E.
    Troussard, X.
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2012, 60 (05): : 343 - 353
  • [8] Renal replacement therapy in children: data from 12 registries in Europe
    van der Heijden, BJ
    van Dijk, PCW
    Verrier-Jones, K
    Jager, KJ
    Briggs, JD
    PEDIATRIC NEPHROLOGY, 2004, 19 (02) : 213 - 221
  • [9] Growth in children on kidney replacement therapy: a review of data from patient registries
    Bonthuis, Marjolein
    Harambat, Jerome
    Jager, Kitty J.
    Vidal, Enrico
    PEDIATRIC NEPHROLOGY, 2021, 36 (08) : 2563 - 2574
  • [10] Growth in children on kidney replacement therapy: a review of data from patient registries
    Marjolein Bonthuis
    Jérôme Harambat
    Kitty J. Jager
    Enrico Vidal
    Pediatric Nephrology, 2021, 36 : 2563 - 2574